David B Ring

This inventor holds 33 USPTO granted patents and 1 EPO patent. Top assignees: Chiron Corporation, Cetus Corporation, Creative Biomolecules, Inc.. Active years: 1986-2008.

USPTO Granted Patents = 33

% Patents Active = 87.9

EPO Patents = 1

Average Co-Inventor Count = 2.3

ph-index = 18

Forward Citations = 1,294(Granted Patents)

Location History:

Redwood City, CA (US) (1986 - 2006)
Palo Alto, CA (US) (1998 - 2008)

Company Filing History:

Creative Biomolecules, Inc.

patents

4. 2 out of 28

Cetus Oncology Corporation

patents

5. 1 out of 1

Creative Biomoelcules, Inc.

patent

6. 1 out of 245

Novartis Vaccines & Diagnostics, Gmbh

patents

7. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2008

Loading Chart...

Areas of Expertise:

Glycogen Synthase Kinase 3

Immuno-Targeting

Humanized Antibodies

Monoclonal Antibodies

Bispecific Antibodies

Cancer Antigens

Nucleic Acids

Tumor Treatment

Immunotoxins

Antibody Class Determination

Biosynthetic Binding Proteins

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7425557 - Inhibitors of glycogen synthase kinase 3 (2008-09-16),

2. 7138497 - Biosynthetic binding proteins for immuno-targeting (2006-11-21),

3. 7053097 - Inhibitors of glycogen synthase 3 kinase (2006-05-30),

4. 7045519 - Inhibitors of glycogen synthase kinase 3 (2006-05-16),

5. 7037918 - Inhibitors of glycogen synthase kinase 3 (2006-05-02),

6. 6489344 - Inhibitors of glycogen synthase kinase 3 (2002-12-03),

7. 6479284 - Humanized antibody and uses thereof (2002-11-12),

8. 6417185 - Inhibitors of glycogen synthase kinase 3 (2002-07-09),

9. 6153618 - Inhibitors of glycogen synthase 3 kinase (2000-11-28),

10. 6143873 - Monoclonal anti-multiple drug resistance antibody, methods of production (2000-11-07),

11. 6106833 - Bispecific antibodies, methods of production and use thereof (2000-08-22),

12. 6057117 - Identification and use of selective inhibitors of glycogen synthase (2000-05-02),

13. 6054561 - Antigen-binding sites of antibody molecules specific for cancer antigens (2000-04-25),

14. 5959084 - Bispecific antibodies, methods of production and uses thereof (1999-09-28),

15. 5948647 - Nucleic acids encoding antigen-binding sites specific for cancer antigens (1999-09-07),

Title: The Innovative Journey of David B Ring

Introduction: David B Ring, a distinguished inventor based in Palo Alto, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: David B Ring holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, David B Ring has worked with leading tech companies, research institutions, and universities, honing his skills and expertise in developing cutting-edge solutions to complex problems.

Collaborations: Throughout his career, David B Ring has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and creativity that has led to the successful development of revolutionary products and technologies.

Conclusion: David B Ring's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor in the tech industry. His contributions continue to inspire the next generation of inventors and shape the future of technology.